Cargando…
Allogeneic Stem Cell Transplantation with CD34+ Cell Selection
The success of allogeneic stem cell transplant is hampered by the development of acute and chronic graft-versus-host disease (GvHD) which has direct impact on treatment-related mortality and morbidity. As a result, T cell depletion through positive selection of CD34+ cells has emerged as a promising...
Autores principales: | Roldan, Elisa, Perales, Miguel Angel, Barba, Pere |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Atlantis Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432362/ https://www.ncbi.nlm.nih.gov/pubmed/34595425 http://dx.doi.org/10.2991/chi.d.190613.001 |
Ejemplares similares
-
Long-term prognosis for 1-year relapse-free survivors of CD34 cell–selected allogeneic hematopoietic stem cell transplantation: a landmark analysis
por: Cho, Christina, et al.
Publicado: (2017) -
The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+selected allogeneic stem cell transplant
por: Alarcon Tomas, Ana, et al.
Publicado: (2021) -
Effects of T-Cell Depletion on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in AML Patients
por: Hobbs, Gabriela Soriano, et al.
Publicado: (2015) -
Antithymocyte globulin exposure in CD34(+) T-cell–depleted allogeneic hematopoietic cell transplantation
por: Lakkaraja, Madhavi, et al.
Publicado: (2022) -
Blockade of TNFα to Improve Human CD34+ Cell Repopulating Activity in Allogeneic Stem Cell Transplantation
por: Senyuk, Vitalyi, et al.
Publicado: (2019)